With twenty years of experience, Michael has substantial experience serving life science companies. He transferred from the firm’s New York City area practice to the Bay Area in September, 2005. Clients served have included: Gilead Sciences, Intuitive Surgical, Corcept Therapeutics, ChemoCentryx, Avinger, Coherus BioSciences, Ardelyx, Immune Design, XOMA, NDC, Affymax, Nektar Therapeutics, Allakos and Oraya Therapeutics. Michael is qualified in external financial reporting, and frequently assists companies with accounting issues, such as revenue recognition, business combinations, and stock-based compensation. Michael serves multi-national organizations as well as a number of emerging growth entities. Michael’s mix of industry activities including being a member of our firm’s life science executive network which allows him to keep abreast of current industry issues. He has worked closely with underwriters, legal counsel, and SEC staff accountants on numerous transactions, including initial public offerings, mergers and acquisitions, debt offerings and follow-on offerings. He has advised companies on disclosures included in publicly-filed documents, such as Registration Statements on Form S-1, Form 10-K, and Form 10-Q. Michael spent two years in the West Sub-Area Professional Practice Group of EY, providing professional guidance and advice on latest developments at the FASB and other technical accounting areas to peers and clients.
Michael works with the Northern California Association of Biosciences Financial Officers (ABFO) and assists with the annual ABFO conference as well as various local educational events.
Michael was awarded a Bachelors of Science in Business Administration from Rider University. He is a certified public accountant in California and New Jersey. Michael is a member of the American Society of Certified Public Accountants and California Society of Public Accountants. He also serves as a Trustee of the Charles Armstrong School.